Differences in Exhaled Breath by Using Ion Mobility Spectrometry (IMS) in Subjects Tested for SARS-CoV-2 Infection (COVID-19 Disease)

NCT04649931 · clinicaltrials.gov ↗

COMPLETED

Status

450

Enrollment

INDUSTRY

Sponsor class

Conditions

SARS (Severe Acute Respiratory Syndrome)
Covid19

Interventions

DEVICE: Ion Mobility Spectrometry (IMS)

Sponsor

B. Braun Melsungen AG

Collaborators

[object Object]